137 related articles for article (PubMed ID: 19493635)
1. Thyroid carcinoma with papillary and squamous features: report of a case with histogenetic considerations.
Rausch T; Benhattar J; Sutter M; Andrejevic-Blant S
Pathol Res Pract; 2010 Apr; 206(4):263-9. PubMed ID: 19493635
[TBL] [Abstract][Full Text] [Related]
2. Primary pure squamous cell carcinoma of the thyroid: report and histogenic consideration of a case involving a BRAF mutation.
Ko YS; Hwang TS; Han HS; Lim SD; Kim WS; Oh SY
Pathol Int; 2012 Jan; 62(1):43-8. PubMed ID: 22192803
[TBL] [Abstract][Full Text] [Related]
3. Mixed medullary-papillary carcinoma of the thyroid: report of a case and review of the literature.
Nangue C; Bron L; Portmann L; Volante M; Ris HB; Monnier P; Andrejevic-Blant S
Head Neck; 2009 Jul; 31(7):968-74. PubMed ID: 19260112
[TBL] [Abstract][Full Text] [Related]
4. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
Fugazzola L; Puxeddu E; Avenia N; Romei C; Cirello V; Cavaliere A; Faviana P; Mannavola D; Moretti S; Rossi S; Sculli M; Bottici V; Beck-Peccoz P; Pacini F; Pinchera A; Santeusanio F; Elisei R
Endocr Relat Cancer; 2006 Jun; 13(2):455-64. PubMed ID: 16728573
[TBL] [Abstract][Full Text] [Related]
5. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
6. "Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass.
Mattioli F; Masoni F; Ponti G; Rossi G; Molteni G; Alicandri-Ciufelli M; Presutti L
Auris Nasus Larynx; 2009 Jun; 36(3):372-5. PubMed ID: 18619747
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.
Asioli S; Erickson LA; Sebo TJ; Zhang J; Jin L; Thompson GB; Lloyd RV
Am J Surg Pathol; 2010 Jan; 34(1):44-52. PubMed ID: 19956062
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma arising in a tall cell papillary carcinoma of the thyroid.
Sutak J; Armstrong JS; Rusby JE
J Clin Pathol; 2005 Jun; 58(6):662-4. PubMed ID: 15917423
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
Erickson LA; Jin L; Nakamura N; Bridges AG; Markovic SN; Lloyd RV
Cancer; 2007 May; 109(10):1965-71. PubMed ID: 17387744
[TBL] [Abstract][Full Text] [Related]
10. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C
Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465
[TBL] [Abstract][Full Text] [Related]
11. Mixed medullary-papillary carcinoma of the thyroid: a case report.
Hasney CP; Amedee RG
Laryngoscope; 2010; 120 Suppl 4():S153. PubMed ID: 21225751
[TBL] [Abstract][Full Text] [Related]
12. [An investigation of BRAF mutation in papillary thyroid carcinoma and its clinical value].
Gong RX; Zhou Y; Luo SH; Zhang L; Zhou B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):310-3. PubMed ID: 19504446
[TBL] [Abstract][Full Text] [Related]
13. Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation.
Kumagai A; Namba H; Mitsutake N; Saenko VA; Ohtsuru A; Ito M; Noh JY; Sugino K; Ito K; Yamashita S
Oncol Rep; 2006 Jul; 16(1):123-6. PubMed ID: 16786134
[TBL] [Abstract][Full Text] [Related]
14. [Squamous cell carcinoma arising in a papillary carcinoma of the thyroid: a case report].
Maamouri F; Goucha A; Ben Mna N; Ben Hassouna J; Debbabi B; Ouslati Z; Boussen H; El May A; Gamoudi A
Tunis Med; 2007 Mar; 85(3):251-3. PubMed ID: 17668586
[TBL] [Abstract][Full Text] [Related]
15. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
16. Metastatic papillary thyroid carcinoma of the submandibular lymph nodes with extensive squamous metaplasia: report of a case.
Kunisue H; Mikami Y; Tanaka K; Sonoo H; Udagawa K; Yamamoto Y; Yamamoto S; Kurebayashi J; Shimozuma K
Surg Today; 2003; 33(10):751-4. PubMed ID: 14513322
[TBL] [Abstract][Full Text] [Related]
17. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M
J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?
Cameselle-Teijeiro J; Abdulkader I; Pérez-Becerra R; Vázquez-Boquete A; Alberte-Lista L; Ruiz-Ponte C; Forteza J; Sobrinho-Simões M
Hum Pathol; 2009 Jul; 40(7):1029-35. PubMed ID: 19269016
[TBL] [Abstract][Full Text] [Related]
19. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
Kim TY; Kim WB; Rhee YS; Song JY; Kim JM; Gong G; Lee S; Kim SY; Kim SC; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2006 Sep; 65(3):364-8. PubMed ID: 16918957
[TBL] [Abstract][Full Text] [Related]
20. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
